Bone Marrow & Stem Cell Transplant

>

Latest News

PTCy Improves Outcomes for Stem Cell Transplants, Regardless of HLA Match
PTCy Improves Outcomes for Stem Cell Transplants, Regardless of HLA Match

July 18th 2024

Patients who underwent hematopoietic cell transplantation had similar outcomes with matched vs mismatched unrelated donors when posttransplant cyclophosphamide was used.

FDA Accepts Application of Tab-Cel, First-in-Class Therapy for EBV+ PTLD
FDA Accepts Application of Tab-Cel, First-in-Class Therapy for EBV+ PTLD

July 17th 2024

BLA for Remestemcel-L to Treat Pediatric SR-aGVHD Resubmitted to FDA
BLA for Remestemcel-L to Treat Pediatric SR-aGVHD Resubmitted to FDA

July 10th 2024

Novel Therapy Boosts Survival After Stem Cell Transplants
Novel Therapy Boosts Survival After Stem Cell Transplants

July 3rd 2024

Ponatinib, Chemo, and Transplant Shows Promise for Long-Term Survival in Ph+ ALL
Ponatinib, Chemo, and Transplant Shows Promise for Long-Term Survival in Ph+ ALL

June 20th 2024